BioLineRx Reports Third Quarter 2019 Financial Results and Provides Corporate Update
- Monday, November 11, 2019, 7:19
- Business
- Add a comment
TEL AVIV, Israel, Nov. 11, 2019 /PRNewswire/ — BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended September 30, 2019 and provides a corporate update. Highlights and…
About the Author
adminasapcorp has written 41779 stories on this site.